First Eagle Investment Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-94,739
Closed -$1.77M 418
2022
Q1
$1.77M Buy
94,739
+45,382
+92% +$817K ﹤0.01% 210
2021
Q4
$1.06M Buy
49,357
+31,500
+176% +$621K ﹤0.01% 153
2021
Q3
$330K Buy
17,857
+15,400
+627% +$310K ﹤0.01% 190
2021
Q2
$53K Buy
+2,457
New +$50K ﹤0.01% 189

Other funds holding OCDX

First Eagle Investment Management's OCDX Position: Q2 2022 in Review

First Eagle Investment Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 94,739 shares — an estimated $1.77M sold.

First Eagle Investment Management first reported a position in OCDX in Q2 2021 and held it in 4 quarters. The position peaked at $1.77M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • First Eagle Investment Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • First Eagle Investment Management sold 94,739 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $1.77M.
  • First Eagle Investment Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2021 and held it in 4 quarters.
  • First Eagle Investment Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $1.77M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on First Eagle Investment Management's 13F filing for Q2 2022, filed 10 Aug 2022.